MoonLake Immunotherapeutics (MLTX) Times Interest Earned (2022 - 2026)

MoonLake Immunotherapeutics' Times Interest Earned history runs 3 years deep, the most recent figure standing at -$30.86 for Q1 2026.

• In Q1 2026, Times Interest Earned rose 98.83% year-over-year to -$30.86; the TTM figure through Mar 2026 stood at -$28.15 (up 99.7% YoY), while the FY2025 annual figure was -$33.78, changed N/A from the prior year.
• Times Interest Earned was -$30.86 for Q1 2026 at MoonLake Immunotherapeutics, up from -$32.71 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of -$22.34 in Q3 2025 to a low of -$24265.3 in Q1 2022.
• Historically, Times Interest Earned has averaged -$4503.2 across 3 years, with a median of -$31.78 in 2025.
• Biggest YoY gain for Times Interest Earned was 98.83% in 2026; the steepest drop was 98.83% in 2026.
• A 3-year view of Times Interest Earned shows it stood at -$24265.3 in 2022, then surged by 99.87% to -$32.71 in 2025, then advanced by 5.64% to -$30.86 in 2026.
• The last three Times Interest Earned figures came in at -$30.86 (Q1 2026), -$32.71 (Q4 2025), and -$22.34 (Q3 2025), per Business Quant data.